Addition of gemcitabine to paclitaxel, epirubicin, and cyclophosphamide adjuvant chemotherapy for women with early-stage breast cancer (tAnGo) : final 10-year follow-up of an open-label, randomised, phase 3 trial
- Submitting institution
-
The University of Birmingham
- Unit of assessment
- 1 - Clinical Medicine
- Output identifier
- 44496661
- Type
- D - Journal article
- DOI
-
10.1016/S1470-2045(17)30319-4
- Title of journal
- The Lancet Oncology
- Article number
- -
- First page
- 755
- Volume
- 18
- Issue
- 6
- ISSN
- 1470-2045
- Open access status
- Compliant
- Month of publication
- May
- Year of publication
- 2017
- URL
-
-
- Supplementary information
-
https://ars.els-cdn.com/content/image/1-s2.0-S1470204517303194-mmc1.pdf
- Request cross-referral to
- -
- Output has been delayed by COVID-19
- No
- COVID-19 affected output statement
- -
- Forensic science
- No
- Criminology
- No
- Interdisciplinary
- No
- Number of additional authors
-
29
- Research group(s)
-
-
- Citation count
- 6
- Proposed double-weighted
- No
- Reserve for an output with double weighting
- No
- Additional information
- -
- Author contribution statement
- The author was the first author.
- Non-English
- No
- English abstract
- -